💊 Search Drugs Recalls

Recent Recalls

210 results found

Medium Risk (Type II)
Drugs
October 6, 2026

PMS-FAMPRIDINE

PMS-FAMPRIDINE 10 mg Tablet: Affected lot may contain foreign material particles.

What to do:

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada..

Medium Risk (Type II)
Drugs
October 6, 2026

PMS-Carvedilol

PMS-Carvedilol 25 mg Tablets: Out-of-specification (Impurity)

What to do:

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada..

Medium Risk (Type II)
Drugs
October 6, 2026

Carvedilol

Carvedilol 25 mg Tablets: Out-of-specification (Impurity)

What to do:

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada..

Medium Risk (Type II)
Drugs
October 5, 2026

PDP-DIPHENHYDRAMINE

PDP-DIPHENHYDRAMINE 25 MG CAPSULE: Out-of-specification (Impurity)

What to do:

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada..

Medium Risk (Type II)
Drugs
October 5, 2026

CARVEDILOL

Carvedilol 25 mg Tablets: Out-of-specification (Impurity)

What to do:

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada..

High Risk (Type I)
Biologic or vaccine
September 25, 2026

SARCLISA

Limited number of Sarclisa single use vials may have been frozen during shipment

What to do:

Only a limited number of units within the lot are affected by this recall.

Medium Risk (Type II)
Drugs
September 24, 2026

Apo-Semaglutide Injection

Apo-Semaglutide Injection : Incorrect dose display

What to do:

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada..